Hot Stock on the Radar: Washington Federal, Inc. (NASDAQ:WAFD), Antares Pharma Inc. (NASDAQ:ATRS)

Washington Federal, Inc. (NASDAQ:WAFD)

The shares of Washington Federal, Inc. (NASDAQ:WAFD) started off the last trading session with the price of $36.1 while closing the day with the price of $35.8. The shares of Washington Federal, Inc. (NASDAQ:WAFD) Fell -0.83% with the Loss of -0.3 points.

The shares of Washington Federal, Inc. (NASDAQ:WAFD) traded with the day volume of 1.55 Million shares whereas its average trading volume is 407.48 Million.

While analyzing the past performance of the stock we can see that the shares of Washington Federal, Inc. (NASDAQ:WAFD) Loss -0.28% in the last week while Falling -0.14% in the last month. Past quarter performance shows the green light with 5.29%. The semi-annual and annual performance shows 13.47% and 8.65% respectively.

Some critical values of the shares of Washington Federal, Inc. (NASDAQ:WAFD) to be discussed here are: the beta which shows the value at 1.18 while Average True Range of Washington Federal, Inc. (NASDAQ:WAFD) demonstrate the value at 0.75. The weekly and monthly volatility of the shares of Washington Federal, Inc. (NASDAQ:WAFD) are indicated at 1.17% and 1.95%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 50.14.

While studying the financial position of the shares of Washington Federal, Inc. (NASDAQ:WAFD), we can see that the Market capitalization of the company is at 3.1 Billion. The shares outstanding for the company is 86.69 Million and the shares float stands at 85.01 Million. The income of the company stand at 180.3 Million while the sales stand at 561.9 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 2.04, Price to Earnings or P/E is at 17.57, Price to Sales P/S show the value of 5.52, the Return on Asset ROA stood at 0.012 and the Return on Equity ROE depicted at 0.091 while Return on Investment ROI is at 0.175.


Antares Pharma Inc. (NASDAQ:ATRS)

Antares Pharma Inc. (NASDAQ:ATRS) started its previous trading session at $2.45 and closed at $2.43 showing a Fell of -2.02 Percent.

The Company traded with an average Volume of 1.3 Million whereas, its Day Volume stood at 1.54 Million.

Looking at the performance of the stock, Antares Pharma Inc. (NASDAQ:ATRS) Loss -12.9% in the last week in its shares price and 22.73% in the last month. Quarterly performance shows a green of 23.98 Percent while Semi-Annual and Annual performances shows a -17.35 and -13.83 percent respectively.

Beta for Antares Pharma Inc. (NASDAQ:ATRS) stands at 0.22 while the ATR (average true range) is at if(document.body.clientWidth>1500){document.write(”)}else{document.write(”)}. The Stock’s Weekly and Monthly Volatility is 7.96% and 6.90% respectively showing a RSI value of 51.7.

While studying the financial position of the shares of Antares Pharma Inc. (NASDAQ:ATRS), we can see that the Market capitalization of the company is at 388.61 Million. The shares outstanding for the company is 159.92 Million and the shares float stands at 141.91 Million.

The Company generated an income of -16700000 and the sales of 54.5 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.11 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 7.13 respectively.

The Return on Assets stands at -0.224, ROE shows a value of -0.443 and ROI for Antares Pharma Inc. (NASDAQ:ATRS) is -0.282 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment